New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
09:59 EDTWBMD, SWKS, TQNT, TRXC, PCL, KRO, GBDC, BNFT, ACRX, SNDK, NCLH, JAZZ, FMI, ADHD, RFMD, MHR, HAFC, CVA, ACOROn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AcelRx (ACRX) initiated with a Buy at Canaccord... Acorda Therapeutics (ACOR) initiated with a Hold at Canaccord... Alcobra (ADHD) initiated with a Buy at Canaccord... Benefitfocus (BNFT) initiated with a Market Perform at William Blair... Cameron (CAM) initiated with a Buy at Gabelli... Covanta (CVA) initiated with an Outperform at Macquarie... Foundation Medicine (FMI) initiated with a Market Perform at William Blair... Golub Capital (GBDC) initiated with an Outperform at Raymond James... Hanmi Financial (HAFC) initiated with an Outperform at Raymond James... Jazz Pharmaceuticals (JAZZ) initiated with a Buy at Canaccord... Kronos Worldwide (KRO) initiated with a Reduce at SunTrust... Magnum Hunter (MHR) initiated with a Hold at Maxim... Norwegian Cruise Line (NCLH) initiated with a Buy at Longbow... Plum Creek Timber (PCL) initiated with an Outperform at RBC Capital... RF Micro Devices (RFMD) initiated with a Market Perform at BMO Capital... SanDisk (SNDK) assumed with an Overweight at Piper Jaffray... Skyworks (SWKS) initiated with a Market Perform at BMO Capital... TransEnterix (TRXC) initiated with a Buy at Sterne Agee... TriQuint (TQNT) initiated with a Market Perform at BMO Capital... WebMD (WBMD) initiated with an Outperform at William Blair.
News For ACRX;ACOR;ADHD;BNFT;CVA;FMI;GBDC;HAFC;JAZZ;KRO;MHR;NCLH;PCL;RFMD;SNDK;SWKS;TRXC;TQNT;WBMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 20, 2015
16:01 EDTHAFCHanmi Financial raises dividend to 11c from 7c per share
Subscribe for More Information
15:04 EDTACRXAcelRx to reduce workforce by approximately 36%
Subscribe for More Information
15:02 EDTACRXAcelRx names Howard Rosen as interim CEO
AcelRx Pharmaceuticals (ACRX) announced the appointment of Howard Rosen as interim CEO of AcelRx, effective April 1. Rosen is a technically trained executive with over 25 years of success growing start-up and mid-size biopharmaceutical companies. Rosen previously held senior-level general management positions and functional roles in strategy, marketing, finance, business development, and research and development at Gilead Sciences (GILD) and ALZA Corporation. Rosen has served on the Board of Directors of AcelRx since 2008 and currently serves on the Board of Directors of Alcobra and several private biopharmaceutical companies.
10:00 EDTNCLH, BNFTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:20 EDTNCLHNorwegian Cruise Line initiated with an Outperform at Wedbush
Subscribe for More Information
05:36 EDTBNFTBenefitfocus initiated with an Outperform at Wells Fargo
Subscribe for More Information
March 19, 2015
08:18 EDTSNDKSanDisk to benefit from 3D NAND, says Morgan Stanley
Subscribe for More Information
March 18, 2015
13:05 EDTJAZZJazz Pharmaceuticals management to meet with Piper Jaffray
Subscribe for More Information
11:25 EDTSWKSStocks with call strike movement; SWKS MU
Subscribe for More Information
10:00 EDTKROOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:17 EDTNCLHNorwegian Cruise Line price target raised to $60 from $51 at Credit Suisse
Subscribe for More Information
06:13 EDTKROKronos Worldwide upgraded to Neutral from Reduce at SunTrust
Subscribe for More Information
March 17, 2015
12:41 EDTCVACovanta shares rise after CEO buys shares
Shares of Covanta are trading higher after the company CEO Stephen Jones disclosed in a filing after the close last night that he purchased 50,000 shares of the company's stock for $21.15 per share on March 13. Covanta shares are higher by 4.25% to $22.10 in midday trading.
10:26 EDTSNDKOptions with increasing implied volatility
Subscribe for More Information
08:07 EDTSNDKNetlist announces positive ruling in patent battles in ULLtraDIMM case
Subscribe for More Information
05:53 EDTSNDKStocks with implied volatility movement; WLL SNDK
Stocks with implied volatility movement; Whiting Petroleum (WLL) 86, SanDisk (SNDK) 36 according to iVolatility.
March 16, 2015
09:22 EDTACRXOn The Fly: Pre-market Movers
Subscribe for More Information
09:01 EDTACORFlex Pharma names Thomas Wessel as Chief Medical Officer
Flex Pharma (FLKS) announced the appointment of Thomas Wessel, M.D., Ph.D., as its Chief Medical Officer, reporting to Christoph Westphal M.D., Ph.D., Flex Pharma’s President, CEO and Chair. Flex Pharma also announced that Elizabeth Woo, M.B.A., has been promoted to Senior VP, Investor Relations and Corporate Communications. Previously, Dr. Wessel has been the Chief Medical Officer of Acorda Therapeutics (ACOR).
07:23 EDTMHRMagnum Hunter announces Eureka Hunter throughput volume of 623,713 MMBtu per day
Eureka Hunter Pipeline, in which Magnum Hunter owns a substantial equity interest, announced that throughput volumes on Eureka Hunter's gas gathering pipeline system located in West Virginia and Ohio, have now reached a new record of approximately 623,713 MMBtu per day on Friday, March 13.
07:01 EDTACRXAcelRx initiates Phase 3 trial for ARX-04
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use